anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Resolution

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 42,534
Current window 24,901-24,930
Pages 1,418
Rows per page 30
Beat: Resolutionclear collectionreset all
18 30 60

Beat

24,901-24,930 of 42,534

filter-aware
81
The table adjusts reported revenue for exchange rates and divestitures/discontinuations to arrive at organic revenue.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
82
Standard financial reconciliation table for non-GAAP metrics.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
83
The table provides a detailed breakdown of adjustments including impairments, restructuring, and other non-GAAP items.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
84
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
85
This slide serves as a glossary/disclosure for non-GAAP metrics, with a navigation sidebar listing other metrics.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
86
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
87
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
88
This slide serves as a glossary for financial metrics, likely part of a larger investor presentation.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
89
The right-hand sidebar acts as a navigation menu for the appendix section.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
90
This slide serves as a glossary/methodology reference for financial reporting.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
91
The slide features a sidebar navigation menu listing various non-GAAP metrics, with the current section 'Adjusted Cash Flows from Operations' and 'Bausch Pharma Total Revenue' highlighted.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
21
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
Includes reference to Nature publication and SITC 2021 presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
Includes trial schema (Part 1/2) and summary of patient characteristics, adverse events, and immune responses.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
The slide illustrates a dual-component therapy (CAR-T + RNA vaccine) and a multi-part clinical trial design.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
Slide 25 of a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
26
Includes a diagram of the mechanism of action and a process flow for the clinical trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
28
The slide outlines the mechanism of a bispecific antibody and the trial structure (dose escalation followed by expansion cohorts).BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
29
Clinical trial data summary slide.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
30
The slide uses a process flow diagram to describe the study design and three summary boxes for key clinical findings.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
31
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
32
The table shows a significant increase in commercial revenues and profit for 2021 compared to 2020.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
33
The chart breaks down revenue into four categories, with COVID-19 vaccine revenues being the primary driver.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
34
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
35
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
36
The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
37
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
38
The table uses a Gantt-style visualization for clinical trial phases, though all shown candidates are currently in Phase 1/2.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
39
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit